Incidence and prognostic significance of fever following intracerebral hemorrhage
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To investigate the incidence and prognostic significance of fever on presentation and during the subsequent 72 hours in patients with spontaneous supratentorial intracerebral hemorrhage (ICH).
Methods: We analyzed 251 patients. On admission, body temperature, Glasgow Coma Scale (GCS) score, age, sex, blood pressure, blood glucose level, and presumed origin of hemorrhage were analyzed. From the initial CT scan, hematoma volume, location, and presence of intraventricular hemorrhage were determined. From the first 72 hours, hematoma enlargement, duration of increased temperatures, blood pressure, and blood glucose level were determined. Outcome was classified on discharge with the Glasgow Outcome Scale (GOS) score.
Results: Outcomes included no symptoms in 23 (9%), moderate disability in 64 (26%), severe disability in 104 (41%), vegetative state in 5 (2%), and death in 55 (22%) patients. Prognostic factors retained from a logistic regression model with a dichotomized GOS scale (GOS score of 1 or 2 versus GOS score of 3 to 5) as response variables were GCS score of 7 or less, age older than 75 years, hematoma volume of more than 60 cm3, ventricular hemorrhage, and presence of a coagulation disorder (p < 0.05). Fever was associated with intraventricular hemorrhage. From 196 patients, data from the first 72 hours were analyzed. A total of 18 patients (9%) had normal temperatures throughout the study. The duration of fever (≥37.5 °C) was less than 24 hours in 66 (34%), 24 to 48 hours in 70 (36%), and more than 48 hours in 42 patients (21%). Independent prognostic factors during the first 72 hours were duration of fever, secondary hemorrhage, GCS score of 7 or less, ventricular hemorrhage, hematoma volume of more than 60 cm3, duration of increased blood pressure of more than 48 hours, and duration of increased blood glucose of more than 48 hours.
Conclusions: The incidence of fever after supratentorial ICH is high, especially in patients with ventricular hemorrhage. In patients surviving the first 72 hours after hospital admission, the duration of fever is associated with poor outcome and seems to be an independent prognostic factor in these patients.
Overwhelming evidence from animal experiments shows that even small variations in brain temperature have a critical effect on the histopathologic and functional consequences of various types of neuronal injury. In these studies, increased temperature after the injury persistently exacerbates the neuronal damage and worsens functional outcome, whereas induced hypothermia seems to be neuroprotective.1-5
Corresponding with the experimental data, several clinical studies of patients with acute stroke demonstrated that increased body temperatures at presentation and during the first few days after the insult are associated with a significantly worse outcome.6-10 In a prospective study by Reith et al.,7 which included 390 stroke patients, body temperature was an independent prognostic factor, with each 1 °C increase in body temperature increasing the relative risk for a poor outcome by 2.2. Treatment with induced moderate hypothermia seems to improve functional outcome in patients with head trauma and severe cerebral infarction.11,12
Although Aring and Merritt noted in 193513 that fever is a more common finding in patients with intracerebral hemorrhage (ICH) than in patients with ischemic stroke, the clinical and prognostic significance of fever has not yet been systematically investigated in patients with ICH. We investigated the incidence, associated clinical and radiologic findings, and prognostic significance of fever on presentation and during the first 72 hours after hospitalization in patients who have had spontaneous supratentorial ICH.
Methods.
Patient selection.
We reviewed the charts and CT scans of 251 consecutive patients with the diagnosis of spontaneous supratentorial ICH who were admitted within 24 hours after onset of symptoms from 1992 to 1996 to the University of Heidelberg Neurological Hospital. Patients who were seen in our emergency rooms only or with incomplete data (n = 17) were not included in this study. Only patients with spontaneous hemorrhage were included. All patients with trauma, intracranial tumors, or primary subarachnoidal hemorrhage were excluded. The presumed cause of hemorrhage was assessed according to patients’ history and clinical, radiologic, or intraoperative findings. Cerebral amyloid angiopathy was diagnosed in patients older than 60 years with cortical or subcortical lobar hemorrhage, especially in the presence of multiple hemorrhages or a history of previous hemorrhages, after the exclusion of other causes of ICH with angiography and MRI. Patient data were reviewed without patient identification, as is required by the local ethics committee standards.
Initial clinical evaluation.
The following features were extracted from the routine medical and neurologic evaluation on admission in the emergency room: age, sex, Glasgow Coma Scale (GCS14) score, body temperature, mean arterial pressure (MAP), and serum glucose levels. For further analysis, the data were categorized using cut-off points commonly used in clinical practice as diagnostic criteria for therapeutic decisions.
The GCS score was classified into 1) 3 to 7, 2) 8 to 13, and 3) more than 13. For patients who arrived already intubated or sedated, the initial GCS score, assessed by the ambulance team, was used.
Temperature was measured orally or rectally. The temperatures were categorized into 1) hypothermic (<36.5 °C), 2) normal (36.5 to 37.4 °C), 3) subfebrile (37.5 to 38.4 °C), and 4) febrile (≥38.5 °C).
Blood pressure (BP) was measured noninvasively using a conventional BP cuff. MAP was calculated from the diastolic and systolic values (MAP = Pdiast + 1/3 × [Psyst − Pdiast]). The MAP values were dichotomized into 1) normotensive and hypotensive (<120 mm Hg) and 2) hypertensive (≥120 mm Hg).
Blood glucose levels were determined using routine laboratory methods and, according to diagnostic criteria for diabetes, grouped into 1) low (<5.5 mmol/L), 2) normal (5.5 to 11.0 mmol/L), and 3) increased (>11.0 mmol/L).
According to the Glasgow Outcome Scale (GOS15), outcome at hospital discharge was determined as 1) death, 2) vegetative state, 3) severely disabled, 4) moderate recovery, and 5) good recovery. For statistical analysis, outcome was dichotomized into 1) poor (GOS 1 or 2), and 2) moderate or favorable (GOS 3 to 5). Patients’ ages were categorized into 1) less than 55 years, 2) 55 to 75 years, and 3) older than 75 years.
Neuroradiologic data.
All patients’ diagnoses were confirmed by CT scanning immediately after hospital admission. The hematoma site was classified as lobar, ganglionic (subclassified into thalamic, putaminous, lateral ganglionic, and caudate), or purely ventricular. Ventricular extension was determined by assessing CT scans for the presence of blood in the ventricles. ICH volume was calculated with the formula for ellipsoids (4/3πabc; a, b, and c represent the respective radii in three dimensions). This method has been demonstrated to estimate the hematoma volume reliably.16 ICH volume was classified as 1) small (<25 cm3), 2) moderate (25 to 60 cm3), or 3) massive (>60 cm3). In patients with atypical ICH, angiography or cranial MRI was performed. To detect hematoma enlargement, secondary CT evaluation was performed if clinical deterioration was evident or routinely after 3 days.
Medical treatment and monitoring.
All patients received standardized medical treatment according to an institutional protocol for ICH. In the initial phase of the disease, patients were monitored in the neurologic critical care unit.
Body core temperature was measured on admission and during the further course orally or rectally at 2-hour intervals. The time intervals were shortened in patients with increased temperatures. Subfebrile temperatures of up to 38.0 °C were tolerated if a patient felt no discomfort. Patients with fever of more than 38.0 °C were initially treated with acetaminophen (1000 mg rectally). If this was not successful, external cooling with cold blankets was started. Fever resistant to these measures was treated with parenteral metamizole (250 to 500 mg) or chlorpromazine (10 to 25 mg).
Routine chest radiography and urine analyses were performed on all patients on the day of admission. A search for infectious causes was started in all patients presenting with fever or newly developing fever. Routine measures consisted of a physical examination, repeat chest radiography, urine sediment and culture, change of all catheters, and laboratory tests for systemic infection including complete blood count and C-reactive protein. The presence of urinary tract infection was defined as significant bacteriuria (>105 cells/μL) or leukocyturia (>20 cells per field of view). The diagnosis of pulmonary infection was established according to clinical and radiologic findings.
BP was closely monitored. In normotensive patients, BP was measured initially in 30-minute intervals. This interval was extended in patients who were persistently normotensive over several hours. In hypertensive patients (diastolic BP >95 mm Hg or systolic BP >160 mm Hg), BP was monitored continuously with an intra-arterial radial or femoral catheter. BP was adjusted to systolic values between 140 and 170 mm Hg. If the systolic BP was persistently higher than 170 mm Hg, antihypertensive treatment was started in most patients with uradipil (an alpha-blocking agent) or clonidine. Hypotensive patients with large space-occupying hematomas were treated with fluids and vasopressor drugs.
Blood glucose levels were monitored quantitatively using bedside tests. The time intervals between blood glucose measurements varied according to baseline values or a history of diabetes. At least three measurements per day were taken, even among patients who were always normoglycemic. Hyperglycemia (blood glucose level >11 mmol/L) was treated with insulin.
Corticosteroids were not used. Hyperosmolar agents, barbiturates, and hyperventilation were not routinely used. Coagulation disorders were reversed as soon as possible using coagulation factors, plasma, or platelets, according to the underlying cause. Electrolytes and fluid levels were closely monitored and adjusted to normal values.
Ventricular drainage was considered a part of medical treatment and was carried out in all patients with evidence of enlarged ventricles on CT scanning. Ventriculostomy was also used for intracranial pressure monitoring. Among patients who did not require ventriculostomy, intracranial pressure monitoring devices were not routinely inserted.
The duration of increased temperature, blood glucose levels, and arterial BP were determined from the single measurements during the observation period of 72 hours and categorized for each variable into 1) always within normal limits, 2) abnormal for less than 24 hours, 3) abnormal for 24 to 48 hours, and 4) abnormal for more than 48 hours.
Surgical treatment.
Indications for hematoma evacuation were made on an individual basis. Patients over 80 years of age and with hematoma volume of less than 10 cm3 were not considered for surgery. In patients with large left-hemispheric hematomas or unfavorable clinical status on hospital admission, the indications for surgery were made restrictively. Hematoma evacuation was performed by osteoplastic trepanation by cortical incision and subsequent gentle suction of the clots using an operating microscope.
Statistical analysis.
Statistical analysis was performed on a personal computer using statistical software (Statview 5.0, SAS, Cary, NC). Chi-square and Fisher’s exact tests were used to determine associations between the variables categorized. To examine the significance of possible prognostic variables, two multiple logistic regression models were fitted to the data set with the dichotomized GOS score (GOS 1 or 2 versus GOS 3 to 5) as the response variable. The first model included all patients, using the following categorized clinical and radiologic features obtained on hospital admission as possible explanatory variables: sex, age, GCS score, MAP, blood glucose level, body temperature, location, hematoma volume, presence of ventricular hemorrhage, and presence of a coagulation disorder. The second model was applied to analyze predictive factors within the first 72 hours. In addition to these variables, the presence of infection; hematoma enlargement or secondary hemorrhage; hematoma evacuation; and the duration (categorized into <24 hours, 24 to 48 hours, and >48 hours) of increased temperature, blood glucose level, and arterial hypertension were included in this model as possible explanatory variables. To achieve statistical comparability, we excluded all patients who died within the first 72 hours in the second model. In both models, the possible explanatory variables were tested in reverse order, starting with all independent variables and then stepwise removing the variable that was least explanatory until all variables remaining in the model contributed with p values of less than 0.05. The level of significance (α) chosen was p < 0.05 for all statistical analyses.
Results.
Clinical and radiologic findings on hospital admission.
Table 1 shows the clinical characteristics of all 251 patients, as used for further statistical analysis. Table 2 shows the radiologic findings and the origin of the hemorrhage. The mean patient age was 63.5 years (SD 12.5 years). The mean length of hospital stay was 16 days (SD 12 days). A total of 209 patients (83%) were transferred to rehabilitation units, primary care centers, or long-term care facilities for additional care. On discharge, clinical outcome was death (GOS 1) in 55 (22%), vegetative state (GOS 2) in 5 (2%), severe disability (GOS 3) in 104 (41%), moderate disability (GOS 4) in 64 (26%), and no remaining symptoms (GOS 5) in 23 patients (9%). The cause of death was herniation in 45 (82%), cardiac complications in 4 (7%), infection in 5 (9%), and unexplained in 1 patient (2%).
Characteristics of all patients separated for the dichotomized outcome (Glasgow Outcome Scale [GOS] 1 or 2 versus GOS 3–5)
Cause and radiologic characteristics of the hematoma separated for the dichotomized patient outcome (Glasgow Outcome Scale [GOS] 1 or 2 versus GOS 3–5)
Univariate analysis with the dichotomized outcome as the response variable revealed a significant association with age, hematoma volume, initial GCS score, blood glucose level, body core temperature, ventricular hemorrhage, and origin of the hemorrhage (classified as presence or absence of coagulation disorders with the inclusion of anticoagulant therapy).
A total of 35 patients (14%) presented with hypothermic temperatures (<36.5 °C). Most patients (n = 169; 67%) had normal temperatures (36.5 to 37.4 °C); 45 patients (18%) had subfebrile body temperatures (37.5 to 38.4 °C). The incidence of fever of 38.5 °C or more was low (n = 2; 1%). The relationship between initial body temperature and outcome is presented in figure 1. Thirty-three percent of patients had poor outcomes (GOS 1 or 2), but no patients who completely recovered (GOS 5) had an increased body temperature (≥37.5 °C) on admission. The mortality rate was lowest in the group of patients presenting with low normal or hypothermic temperatures of less than 36.5 °C (11% versus 22% in the overall sample).
Figure 1. Initial temperature and outcome (Glasgow Outcome Scale [GOS] score 1 [death] through 5 [no symptoms]) in all 251 patients, p < 0.005. The absolute number of patients is indicated above the bars, which indicate the relative frequencies for each outcome group. Shaded bars, <37.5 °C; hatched bars, ≥37.5 °C.
Increased temperatures on admission were associated with the presence of intraventricular blood. Thirty-four of 129 patients (26%) had intraventricular hemorrhage, but only 13 of 122 patients (10%) without intraventricular hemorrhage had abnormal temperatures of 37.5 °C or more (p = 0.001). No association was found between the location of the hemorrhage and increased temperatures. Patients with thalamic hemorrhages did not show a higher incidence of fever.
Prognostic factors retained from the multiple logistic regression model were initial GCS score of 7 or less, age of more than 75 years, hematoma volume of more than 60 cm3, ventricular hemorrhage, and presence of a coagulation disorder (table 3). The initial body temperature was not accepted as an independent explanatory factor in this model. After adding temperature to the “final” model selected, temperature was still not accepted as an explanatory variable.
Multiple logistic regression analysis of poor outcome (Glasgow Outcome Scale 1 or 2) for all 251 patients
Findings during the first 72 hours.
For 196 patients, follow-up data were obtained for 72 hours after admission. Fifty-five patients were not included in this analysis because of death (n = 30) or discharge (n = 16) within the first 72 hours or incomplete data (n = 9). In the subgroup of 196 patients, outcome was death (GOS 1) in 24 (12%), vegetative state (GOS 2) in 5 (3%), severe disability (GOS 3) in 88 (45%), moderate disability (GOS 4) in 57 (29%), and no remaining symptoms (GOS 5) in 22 (11%) patients.
Most patients were treated medically. Surgical hematoma evacuation was performed in 37 patients (19%); 47 patients (24%) were treated with a ventriculostomy because of hydrocephalus.
The incidence of increased body temperatures was high. Only 18 patients (9%) had normal temperatures throughout the observation period (<37.5 °C). In 178 patients (91%), temperature was 37.5 °C or more at least once during the observation period, and in 83 patients (42%) 38.5 °C or more at least once during the observation period. The duration of increased temperatures (≥37.5 °C) during the 72-hour observation period was less than 24 hours in 66 (34%), 24 to 48 hours in 70 (36%), and more than 48 hours in 42 patients (21%).
The duration of increased blood glucose levels (>11 mmol/L) during the 72-hour observation period was less than 24 hours in 64 (33%), 24 to 48 hours in 20 (10%), and more than 48 hours in 12 patients (6%). Blood glucose level was less than 11 mmol/L throughout the observation period in 100 patients (51%).
Arterial hypertension (MAP > 120 mm Hg) was present for less than 24 hours in 98 (50%), 24 to 48 hours in 62 (32%), and more than 48 hours in 27 patients (14%). Only 9 patients (5%) had normal BP throughout the observation period.
Pulmonary infection was diagnosed within the first 72 hours in 84 patients (43%); urinary tract infection, in 69 patients (35%). The neurologic complications encountered were hematoma enlargement or secondary hemorrhage in 24 patients (12%) and symptomatic epilepsy in 25 patients (13%).
The multiple regression analysis for the 196 patients with 72-hour follow-up with the dichotomized GOS score as the dependent variable revealed hematoma enlargement or secondary hemorrhage, ventricular hemorrhage, initial GCS score of 7 or less, hematoma volume of more than 60 cm3, duration of increased BP of more than 48 hours, duration of increased blood glucose level of more than 48 hours, and duration of fever of 37.5 °C or more as independent prognostic factors (table 4). In contrast to the first model calculated for all patients, age and coagulation disorders were not significant factors, probably because of the higher early mortality rate of the very elderly patients and of patients with coagulation disorders. Presence of infection, hematoma location, and hematoma evacuation were also rejected as possible independent prognostic factors. After adding infection to the final model selected, infection still was not accepted as an explanatory variable, whereas duration of fever remained significant.
Multiple logistic regression analysis of poor outcome (Glasgow Outcome Scale 1 or 2) for 196 patients with follow-up over 72 hours
The relationship between duration of temperature of 37.5 °C or more and outcome is depicted in figure 2. All patients with a poor outcome (GOS 1 or 2) had increased body temperatures at least once. Forty-four percent of the patients with favorable outcomes (GOS 4 or 5), but 83% of the patients with poor outcomes (GOS 1 or 2), had increased temperatures for more than 24 hours.
Figure 2. Duration of fever (body core temperature ≥37.5 °C) during the first 72 hours from 191 patients who survived this period of time and outcome (Glasgow Outcome Scale [GOS] score 1 [death] through 5 [no symptoms]), p < 0.0001. The absolute number of patients is indicated above the bars, which represent the relative frequencies for each outcome group. Dotted bars, 0 hours; gray bars, 0 to 24 hours; hatched bars, 24 to 48 hours; black bars, >48 hours.
Discussion.
In this study we found that fever is common among patients with ICH and that the duration of fever in the first 72 hours is an independent prognostic factor. Other factors influencing outcomes of patients (i.e., ventricular hemorrhage, blood glucose level, BP, hematoma volume, secondary hemorrhage, GCS score, and age) were similar to those found in various previous studies and are not discussed further here (for an overview, see reference 17).
Research in experimental cerebral ischemia and traumatic brain injury in animals revealed a variety of possible mechanisms by which hyperthermia contributes to a worse outcome (for an overview, see reference 18). Although the metabolic and circulatory responses are not completely comparable with the situation in patients with head trauma or ischemic stroke, the basic pathophysiologic principles of hyperthermia probably also apply to patients with ICH.
Fever was present in 19% of all patients on admission but occurred in almost all (91%) patients at least once during the first 72 hours after hospitalization. Although the comparability with other studies is limited, the incidence of fever in patients with ischemic stroke seems to be similar on presentation but lower during the further clinical course.7,9,19 In the large study of Reith et al.,7 25% of all patients with ischemic infarction presented with body core temperatures of more than 37.5 °C. During the first few days, fever was present in 31% to 61% of patients with ischemic stroke.9,10,19 Although comparable data for ICH are lacking, patients with traumatic and subarachnoid hemorrhage seem to have a similarly high incidence of fever. Albrecht et al.20 observed fever of more than 38.0 °C in 70% of patients after subarachnoid hemorrhage and in 68% after closed-head injury. Fever occurred in 78 of 107 patients (73%) with subarachnoid hemorrhage.21
Our study was designed to test the hypothesis that fever is a prognostic factor in patients with ICH. To differentiate the exact origin of fever, which is often not possible in an intensive care setting, is beyond the scope of this article. Multiple factors may contribute to the high incidence of fever in patients with ICH. Acute or chronic infection is a risk factor for ischemic stroke.22 If this mechanism is also applied to ICH, the high incidence of fever could be partly explained as a sign of infection, but an association of ICH with recent infection has not been investigated.
Patients in the intensive care unit, especially patients with stroke, are at a high risk for hospital-acquired infections. According to our findings, an incidence of urinary tract and pulmonary infections of up to 50% has been reported.19,23,24 In our study, we could not differentiate between simple infection and the presence of a systemic inflammatory response, so probably not every case of infection, such as an uncomplicated urinary infection, can be considered as a cause of fever. The high rate of patients presenting with fever on hospital admission and the higher prevalence of fever compared with ischemic stroke are additional arguments against infection as the only cause of fever in the patients in this study. In contrast, we may have failed to diagnose subclinical infections as a cause of fever.
The logistic regression analyses indicate that the duration of fever within the first 72 hours is not only associated with poor outcome but also may contribute as an independent factor to the clinical outcome—at least for patients who survive this period of time—but the use of a multiple regression model to detect independent prognostic factors has limitations because it can provide information only about the parameters that are considered, may overlook other uncommon but possibly crucial factors, and heavily depends on the model-building strategy. Therefore, our results should be interpreted with caution and must be confirmed by future studies.
The extent to which fever can be attributed to hematomas and how ICH produces fever remain speculative. Direct damage to the thermoregulatory centers in the hypothalamus and brainstem has been anecdotally reported as the cause of severe hyperthermia.25,26 This is probably not a major factor in our study in patients with supratentorial hemorrhage. In our study, fever was independent of the hematoma location; in particular, thalamic hemorrhage was not associated with the presence of fever, but fever was strongly associated with intraventricular hemorrhage. Some limited clinical and experimental evidence shows that intraventricular hemorrhage induces hyperthermia. Experimental intraventricular hemorrhage and case reports of children with intraventricular hemorrhage suggest that mechanical irritation of the hypothalamic thermoregulatory centers by the intraventricular blood results in hyperthermia.27-29 An alternative explanation for the association between intraventricular hemorrhage and worse outcome is that ventricular hemorrhage simply indicates a more severe disease with higher mortality and complication rates.
In interpreting our results and those of other studies concerning the relationship between body temperature and brain injury, some methodologic factors should be considered. Different sites can be used to determine the body core temperature, including the tympanum, rectum, mouth, bladder, esophagus, and pulmonary artery. In our retrospective study, we used the temperature measured in the mouth or rectum, as documented in the medical records. The site could be varied in one patient, depending on a patient’s cooperation, position, or where the temperature was measured (e.g., in the emergency room, operating theater, or intensive care unit). Although false-high measurements seem unlikely, an improper measurement technique could have led to false-low results. Also, measurements of the body core temperature may underestimate the temperature in the brain. Studies of head trauma and stroke patients comparing body core and brain temperatures have shown that, in the acute phase of brain injury, the brain temperature exceeds the body core temperature by up to 2.7 °C.30,31 Also, in a clinical setting, the body temperature is heavily influenced by drugs producing fever, and therapeutic interventions targeted to treat fever or by the side effects of a concomitant therapy, such as analgesic drugs or nimodipine.32
For analysis of the duration of fever during the first 72 hours, we excluded all patients from this analysis who died during this time. This procedure was inevitable to achieve statistical homogeneity but had two consequences: 1) with the exclusion of very ill patients, the subgroup used for the analysis of the first 72 hours after ICH had a more favorable outcome compared with all patients; and 2) our results obtained during the first 72 hours apply only to patients who survived this period of time.
Because of the retrospective nature of our study, we did not assess the long-term outcome after discharge from the hospital. Portenoy et al.33 did not find significant differences in outcome within 2 weeks after hemorrhage and follow-up examination. Although functional deterioration after the acute stage of the disease is unlikely, patients who are severely disabled on discharge may improve and eventually become independent after rehabilitation. This would not affect the results of our study because we summarized data from patients with GOS scores of 3 to 5.
Although the risk for death within the first hours after ICH is predominantly determined by the extent of neuronal damage from the expanding hematoma or its mass effects, delayed increase of intracerebral pressure, neurologic deterioration, and death in the next few days mainly results from the formation of perifocal brain edema.34,35 Two cardinal mechanisms, inflammation and ischemia, mainly contribute to brain edema after ICH.36-38 Analogous to ischemic infarction and head trauma, one may assume that hyperthermia exaggerates the development of brain edema in patients with ICH, whereas decreasing the body temperature to normal or even hypothermic values may decrease the extent of brain edema and secondary neuronal damage.
Our results add to the convincing body of the evidence that fever augments neuronal damage and worsens clinical outcome after brain injury. Our study shows that fever is a common symptom in patients with hemorrhagic stroke and that its duration during the initial phase of disease is associated with poor outcome. Although the possible benefit from therapeutic measures to decrease body temperature is not yet proved, monitoring body temperature carefully and treating fever rigorously in patients with ICH seems justified.
- Received December 7, 1998.
- Accepted August 14, 1999.
References
- ↵
-
Dietrich W, Busto R, Valdes I, Loor Y. Effects of normothermic versus mild hyperthermic forebrain ischemia in rats. Stroke 1990;21:1318–1325.
- ↵
- ↵
Azzimondi G, Bassein L, Nonino F, et al. Fever in acute stroke worsens prognosis: a prospective study. Stroke 1995;26:2040–2043.
- ↵
- ↵
- ↵
Castillo J, Davalos A, Marrugat J, Noya M. Timing for fever-related brain damage in acute ischemic stroke. Stroke 1998;29:2455–2460.
- ↵
- ↵
Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998;29:2461–2466.
- ↵
- ↵
Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;323:81–83.
- ↵
Jennett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet 1975;335:480–484.
- ↵
Broderick J, Brott T, Duldner J, Tomsick T, Huster G. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993;24:987–993.
- ↵
Kase C, Crowell R. Prognosis and treatment of patients with intracerebral hemorrhage. In: Kase C, Caplan L, eds. Intracerebral hemorrhage. Boston:Butterworth-Heinemann, 1994:467–489.
- ↵
Ginsberg M, Busto R. Combating hyperthermia in acute stroke. Stroke 1998;29:529–534.
- ↵
- ↵
- ↵
- ↵
Grau AJ, Buggle F, Becher H, et al. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology 1998;50:196–203.
- ↵
Kalra L, Yu G, Wilson K, Roots P. Medical complications during stroke rehabilitation. Stroke 1995;26:990–994.
- ↵
- ↵
Wijdicks E, St. Louis E. Clinical profiles predictive of outcome in pontine hemorrhage. Neurology 1997;49:1342–1346.
- ↵
Kitanaka C, Inoh Y, Toyoda T, Sasaki T, Eguchi T. Malignant brain stem hyperthermia caused by brain stem hemorrhage. Stroke 1994;25:518–520.
- ↵
- ↵
- ↵
- ↵
Schwab S, Spranger M, Aschoff A, Steiner T, Hacke W. Brain temperature monitoring and modulation in patients with severe MCA infarction. Neurology 1997;48:762–767.
- ↵
- ↵
Portenoy R, Lipton R, Berger A, Lesser M, Lantos G. Intracerebral haemorrhage: a model for prediction of outcome. J Neurol Neurosurg Psychiatry 1987;50:976–979.
- ↵
- ↵
Mendelow A. Mechanisms of ischemic brain damage with intracerebral hemorrhage. Stroke 1993;24 (suppl 1):115–117.
- ↵
-
Rosenberg G, Navratil M. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 1997;48:921–926.
- ↵
Figueroa B, Keep R, Betz A, Hoff J. Plasminogen activators potentiate thrombin-induced brain injury. Stroke 1998;29:1202–1208.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Article
Association of systemic secondary brain insults and outcome in patients with convulsive status epilepticusA post hoc study of a randomized controlled trialCandice Fontaine, Virginie Lemiale, Matthieu Resche-Rigon et al.Neurology, September 10, 2020 -
Article
Novel Score for Stratifying Risk of Critical Care Needs in Patients With Intracerebral HemorrhageRoland Faigle, Bridget J. Chen, Rachel Krieger et al.Neurology, March 31, 2021 -
Articles
White matter lesions and poor outcome after intracerebral hemorrhageA nationwide cohort studyS.-H. Lee, B.J. Kim, W.-S. Ryu et al.Neurology, May 10, 2010 -
Articles
Warfarin-related intraventricular hemorrhageImaging and outcomeA. Biffi, T.W.K. Battey, A.M. Ayres et al.Neurology, November 02, 2011